KIMBERLY MARCEL: Open Payments
NPI 1154850204 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 12 payments from 11 companies in 2025. Trend: 2023 $483 · 2024 $670 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 2 | $108 |
| UROGEN PHARMA, INC. | 1 | $39 |
| Astellas Pharma US Inc | 1 | $33 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| ConvaTec Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
| COLOPLAST CORP | 1 | $18 |
Products named: XYOSTED, Xtandi, JELMYTO, PROLARIS, AQUACEL AG+, Exparel, Bulkamid, APLIGRAF.
Industry payments across LA — which companies pay providers there.
